C-peptide is a natural part of insulin production in the human body. In T1D, we take insulin injections but do not replace our c-peptide. Could c-peptide replacement therapy be a crucial element to effective treatment? We speak with Dr. John Wahren, a leading investigator in C-peptide replacement studies, about the possible missing link in T1D treatment. Visit www.cebix. com to learn more about C-peptide.
You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.